New Updates About Padmashree Dr DY Patil Institute of Pharmaceutical Science & Reserach, Pune
- 
                    05 September, 2025 : Padmashree Dr DY Patil Institute of Pharmaceutical Science & Reserach, Pune secured rank 35 in pharmacy category in the NIRF 2025 rankings. 
Table of Content
Padmashree Dr DY Patil Institute of Pharmaceutical Science & Reserach, Pune Popular Courses
Average Fees
                        
                        
                                                            ₹1,80,000
                                                    
                    
Highest Package
                        
 ₹8 LPA
                    
Admission 2025
View BrochureAverage Fees
                        
                        
                                                            ₹2,30,000
                                                    
                    
Highest Package
                        
 ₹15 LPA
                    
Admission 2025
View BrochureAverage Fees
                        
                        
                                                                                                
                                    Get Fees Details
                                    
                                                                                    
                    
Highest Package
                        
-
                    
Admission 2025
View BrochurePadmashree Dr DY Patil Institute of Pharmaceutical Science & Reserach, Pune B.Pharm Rankings
| Publisher | Year | Ranking | 
|---|---|---|
| nirf | 2025 | 35 / 100 | 
| nirf | 2024 | 36 / 100 | 
| nirf | 2022 | 41 / 125 | 
Padmashree Dr DY Patil Institute of Pharmaceutical Science & Reserach, Pune M.Pharm Rankings
| Publisher | Year | Ranking | 
|---|---|---|
| nirf | 2024 | 36 / 100 | 
 
                                                                                     
                                        
                                                                             
                                        
                                                                             
                                        
                                                                             
                                        
                                                                                     
                                                        